Usa covid-19 outbreak testing Usa

Sorrento Therapeutics to develop cellular vaccine for Covid-19

Reading now: 671
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Sorrento Therapeutics has started a programme to develop a decoy cellular vaccine, STI-6991, against Covid-19 coronavirus infection.

The company is in discussions with the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA) on IND-enabling studies, chemistry, manufacturing and controls, clinical protocol and end-points required to potentially gain accelerated approval.

After the FDA provides guidance, the company intends to file an application seeking approval for human clinical trials. STI-6991 is an I-Cell cellular vaccine that comprises replication-deficient human erythroleukemia K562 cells, which express

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA